Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

This study is testing a cell therapy using special immune cells called regulatory T cells (Tregs) to treat neurodegenerative diseases like ALS (Lou Gehrig's disease). These cells may help calm the harmful inflammation that damages the nervous system. **You may be eligible if...** - You are between 18 and 70 years old - You have a confirmed diagnosis of ALS (amyotrophic lateral sclerosis) or another neurodegenerative disease covered by the study - Any current ALS medications (like riluzole or edaravone) have been at a stable dose for at least one month - It has been at least two weeks since any major surgery **You may NOT be eligible if...** - You have a serious infection or uncontrolled medical condition - You have recently received certain other experimental treatments - You do not meet the specific diagnosis criteria confirmed by international standards Talk to your doctor to see if this trial is right for you.